Federal grants to Glycan Therapeutics Corporation
Glycan Therapeutics Corporation in Raleigh, North Carolina received $15.0 million in federal grants from fiscal 2021 to 2025, across 14 awards. Its largest program was Biomedical Research and Research Training, with $12.9 million. In fiscal 2025 it was awarded $3.2 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$15.0 million
- Awards14
- Awarded in FY 2025$3.2 million
- Largest award$2.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $3.0 million |
| FY 2022 | 4 | $1.3 million |
| FY 2023 | 6 | $3.2 million |
| FY 2024 | 4 | $4.4 million |
| FY 2025 | 4 | $3.2 million |
Programs that fund Glycan Therapeutics Corporation
| Program | Awards | Amount |
|---|---|---|
| Biomedical Research and Research Training | 11 | $12.9 million |
| Cardiovascular Diseases Research | 2 | $1.7 million |
| Oral Diseases and Disorders Research | 1 | $347,537 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 14 | $15.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of anticoagulant sulfated glycans - sulfated glycan 8-MER is a carbohydrate-based compound with anticoagulant activity. The goal of this project is to replace animal-sourced low-molecular weight heparin (LMWH) with the 8- mer. Lmwhs are partially depolymerized natural products of heparin | Biomedical Research and Research Training | August 15, 2023 | $2.5 million |
| Synthesis of the library of heparan sulfate hexasaccharide mimetics - project summary: heparan sulfate (HS) play roles in many important biological events, including cancer metastasis, anti- coagulation, and alzheimer’s disease development. Hs structures in nature are heterogeneous with a wide range | Biomedical Research and Research Training | September 20, 2023 | $2.4 million |
| Development of heparan sulfate-based therapeutics to treat inflammatory diseases - abstract more than 60 million americans consume acetaminophen (APAP) on a weekly basis. Unfortunately, an overdose of apap causes liver toxicity and is responsible for over half of acute liver failure cases in the us. | Biomedical Research and Research Training | September 6, 2023 | $2.4 million |
| Development of analytical methods for glycosaminoglycans from biological sources - this sbir phase II proposal is aimed to develop a lc-ms/ms based method to analyze heparan sulfate and chondroitin sulfate with sub-nanogram quantities. Heparan sulfate and chondroitin sulfate are highly sulfated poly | Biomedical Research and Research Training | September 16, 2022 | $2.0 million |
| Development of a new carbohydrate-based anticoagulant drug | Cardiovascular Diseases Research | October 26, 2020 | $1.7 million |
| Diverse heparan sulfate oligosaccharide libraries for understanding and therapeutically manipulating glycosaminoglycans | Biomedical Research and Research Training | February 15, 2021 | $1.5 million |
| Developing heparan sulfate glycan array | Biomedical Research and Research Training | May 10, 2021 | $968,047 |
| Development of?a sensitive?method to measure heparan sulfate 6-O-ENDOSULFATASE - the proposal is aimed to develop a sensitive method to measure the activity of heparan sulfate 6-O-ENDOSULFATASE (SULF). Sulf is an enzyme that removes the 6-O-SULFO groups from heparan sulfate polysaccharides to modula | Biomedical Research and Research Training | January 24, 2023 | $349,927 |
| Sulfated carbohydrates for the treatment of periodontitis - abstract periodontitis affects over half of the american population and has no reliable form of treatment for any stage and grade of the disease besides antibiotics, tooth root scaling and planing and periodontal surgery with highly variabl | Oral Diseases and Disorders Research | September 1, 2023 | $347,537 |
| Construction of chondroitin sulfate microarray - project title: construction of chondroitin sulfate microarray the proposal is aimed to develop a high throughput method to study the interactions between chondroitin sulfate (CS) and proteins. Cs is a member of glycosaminoglycan family displaying a wi | Biomedical Research and Research Training | April 26, 2022 | $331,634 |
Questions people ask
How much federal grant money does Glycan Therapeutics Corporation get?
$15.0 million in 14 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Glycan Therapeutics Corporation the most?
The Department of Health and Human Services, with $15.0 million in 14 awards.
What is Glycan Therapeutics Corporation's largest federal grant?
$2.5 million under Biomedical Research and Research Training, with its first action in the period on August 15, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Glycan Therapeutics Corporation?
Its largest are Biomedical Research and Research Training, Cardiovascular Diseases Research and Oral Diseases and Disorders Research.
Other grant recipients in Raleigh
- North Carolina Department of Health & Human Services
- North Carolina Department of Public Instruction
- Transportation North Carolina Department
- North Carolina Department of Public Safety
- North Carolina Department of Environmental Quality
- North Carolina Department of Public Instruction
- Department of Commerce North Carolina
- Department of Information Technology
Largest federal grant recipients in North Carolina · Federal grants in North Carolina